CD86 and myeloid sarcoma: Our data suggested that the proportion of CD11b+CD86+ subsets and CD11b+CD206+ subsets was increased significantly in the MS group positively correlated with elongation compared with the control group, and in particular, the levels of CD11b+CD86+ subsets were much higher.